A Novel Coronavirus from Patients with Pneumonia in China, 2019.

PubWeight™: 7.78‹?› | Rank: Top 0.1%

🔗 View Article (PMID 31978945)

Published in N Engl J Med on January 24, 2020

Authors

Na Zhu1, Dingyu Zhang1, Wenling Wang1, Xingwang Li1, Bo Yang1, Jingdong Song1, Xiang Zhao1, Baoying Huang1, Weifeng Shi1, Roujian Lu1, Peihua Niu1, Faxian Zhan1, Xuejun Ma1, Dayan Wang1, Wenbo Xu1, Guizhen Wu1, George F Gao1, Wenjie Tan1, China Novel Coronavirus Investigating and Research Team

Author Affiliations

1: From the NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (N.Z., W.W., J.S., X.Z., B.H., R.L., P.N., X.M., D.W., W.X., G.W., G.F.G., W.T.), and the Department of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University (X.L.) - both in Beijing; Wuhan Jinyintan Hospital (D.Z.), the Division for Viral Disease Detection, Hubei Provincial Center for Disease Control and Prevention (B.Y., F.Z.), and the Center for Biosafety Mega-Science, Chinese Academy of Sciences (W.T.) - all in Wuhan; and the Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China (W.S.).

Associated clinical trials:

Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection | NCT04251871

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection (NoCovid) | NCT04290858

Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19. (NOSARSCOVID) | NCT04290871

Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients | NCT04293887

Hypertension in Patients Hospitalized With COVID-19 (HT-COVID19) | NCT04318301

Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study. (BARI-COVID) | NCT04320277

A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 | NCT04324996

The Vietnam Chloroquine Treatment on COVID-19 (VICO) | NCT04328493

Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19 | NCT04349592

The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 | NCT04357340

Ivermectin and Nitazoxanide Combination Therapy for COVID-19 | NCT04360356

Passive Immunity Trial of Nashville II for COVID-19 (PassItOnII) | NCT04362176

Observational Cohort of COVID-19 Patients at Raymond-Poincare (COVID-RPC) | NCT04364698

Repurposing of Chlorpromazine in Covid-19 Treatment (reCoVery) | NCT04366739

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 (TREATNOW) | NCT04372628

Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs (ACICOVID) | NCT04373759

Effect of COVID-19 Pandemic on Pediatric Cancer Care | NCT04374838

CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19 (CORONA) | NCT04378244

Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia | NCT04381858

Non-invasive Ventilatory Support of Patients Affected by COVID-19 (WARd-COVID) | NCT04382235

Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection | NCT04391127

COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO) | NCT04401436

Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients (COVELEC) | NCT04414059

Primary Prevention of Infection by COVID-19 in Health Providers (PI-Covid-19) | NCT04420260

Registry on NEN Patients and COVID-19 | NCT04444401

Perceptions of Undergraduate Students and Teaching Staff on Online Teaching | NCT04466371

Evaluating Clinical Parameters of COVID-19 in Pregnancy (COpregVID) | NCT04470583